GlassScriptPhysician profile
Michael A Stickler
NPI 1962456723
$12,139.72
in general payments reported to CMS, 2019-2025
27 companies · $8,516 in 2025
The $8,516 reported for 2025 was more than what 95% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $465 · 2020: $376 · 2021: $686 · 2022: $862 · 2023: $890 · 2024: $343 · 2025: $8,516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,675 · Education: $2,581 · Travel and Lodging: $1,893 · Food and Beverage: $1,601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,675.00 |
| Education | $2,580.94 |
| Travel and Lodging | $1,892.67 |
| Food and Beverage | $1,600.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $8,257.19 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Abbvie INC. | $853.27 | 2019-2025 | Rinvoq, Skyrizi, Botox |
| Amgen INC. | $452.31 | 2019-2025 | Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $362.19 | 2019-2025 | Ilumya, Blu-U |
| Genzyme Corporation | $349.50 | 2019-2025 | |
| Ucb, INC. | $340.77 | 2020-2024 | Cimzia, Bimzelx |
| Lilly USA, LLC | $286.15 | 2020-2023 | Taltz |
| Janssen Biotech, INC. | $216.33 | 2020-2025 | Tremfya |
| Zimmer Biomet Holdings, INC. | $162.91 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $125.78 | 2021-2023 | Libtayo |
| Organogenesis INC. | $107.17 | 2021-2025 | Apligraf, Puraply |
| Novartis Pharmaceuticals Corporation | $99.39 | 2020-2024 | |
| Leo Pharma INC. | $77.45 | 2019-2023 | Adbry |
| Pfizer INC. | $57.63 | 2022-2025 | |
| Allergan, INC. | $54.91 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sensus Healthcare, INC. | $39.88 | 2024 | |
| Dusa Pharmaceuticals, INC. | $39.81 | 2019 | |
| Arcutis Biotherapeutics, INC. | $37.42 | 2023 | |
| Dermira, INC. | $27.79 | 2020 | |
| Celgene Corporation | $27.42 | 2019 | |
| Incyte Corporation | $27.22 | 2021 | |
| Galderma Laboratories, L.P. | $26.98 | 2020-2021 | |
| Stimlabs LLC | $26.02 | 2025 | Allacor P |
| Sanofi-Aventis U.S. LLC | $23.91 | 2021 | |
| Paratek Pharmaceuticals, INC. | $20.36 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $20.18 | 2025 | Sotyktu |
| Convatec INC. | $19.78 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Stickler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.